{"id":8374,"date":"2026-03-25T16:35:40","date_gmt":"2026-03-25T16:35:40","guid":{"rendered":"https:\/\/total-locker-service.com\/blog\/?p=8374"},"modified":"2026-03-25T16:46:42","modified_gmt":"2026-03-25T16:46:42","slug":"blog-covert-administration-of-medicines-in-care-homes","status":"publish","type":"post","link":"https:\/\/total-locker-service.com\/blog\/blog-covert-administration-of-medicines-in-care-homes\/","title":{"rendered":"Covert Administration of Medicines in Care Homes: Legal Process, Best Interests and Documentation"},"content":{"rendered":"\n

Covert administration means giving a medicine in a disguised form so the person does not know they are taking it, such as hiding it in food or drink. In care homes, this is one of the most sensitive areas of medicines management because it sits at the point where safety, consent, capacity and legal process all meet.<\/p>\n\n\n\n

\"Convert<\/figure>\n\n\n\n

That is why covert administration should never be treated as a convenience measure or a shortcut for difficult medicines rounds. It is only likely to be appropriate where the person is actively refusing an essential medicine, lacks capacity to understand the consequences of that refusal for that specific decision, and covert administration is the least restrictive option after other approaches have been tried.<\/p>\n\n\n\n

For care homes, the practical message is straightforward. If the legal process is weak, the whole arrangement is weak. A resident\u2019s care plan, the medicines record, the best-interests process and the pharmacy advice all need to line up. Without that, staff risk moving from supported care into unlawful or unsafe practice.<\/p>\n\n\n\n

If you are reviewing your wider medicines storage system, see our comprehensive guide to medical cabinets<\/a> and our medical cabinet security solutions<\/a>.<\/p>\n\n\n\n

Why covert administration is treated differently<\/h2>\n\n\n\n

Most medicines decisions in care homes are operational. They involve storage, timing, documentation and staff competence. Covert administration is different because it starts with a person refusing treatment. That refusal must be respected if the person has capacity to make the decision.<\/p>\n\n\n\n

This matters because refusal on its own is not enough. A resident may say no to a tablet because it tastes unpleasant, because they do not understand what it is for, because they are frightened, because they are tired, or because the formulation is hard to swallow. Those issues should be explored first.<\/p>\n\n\n\n

In practice, good homes do not jump straight from refusal to disguise. They pause and ask what is actually happening. Is the medicine still needed? Is the dose too large? Is the resident distressed? Would a liquid, dispersible, patch or different schedule solve the problem? That problem-solving stage is not a formality. It is part of the least restrictive approach required by the Mental Capacity Act framework.<\/p>\n\n\n\n

Capacity comes first<\/h2>\n\n\n\n

Before a best-interests decision can be made, there must be a decision-specific capacity assessment showing that the person lacks capacity to decide about that medicine or medicines. Except in emergencies, that assessment should be recorded before the best-interests decision is made.<\/p>\n\n\n\n

That point is critical in care homes because capacity is not all-or-nothing. A resident may lack capacity for one medicines decision and not another. Capacity may also fluctuate. A person who is confused during an acute infection may later regain enough understanding to make their own decision.<\/p>\n\n\n\n

A strong care-home process therefore avoids blanket wording such as \u201cresident lacks capacity for medicines\u201d. The safer wording is specific. Which medicine? Which decision? What assessment was carried out? When was it done? Who made it? That level of precision protects both the resident and the staff team.<\/p>\n\n\n\n

The best-interests meeting is the turning point<\/h2>\n\n\n\n

If the resident lacks capacity for the medicines decision, the next step is a formal best-interests process. Care-home staff should have a meeting with healthcare professionals and family members to discuss covert administration and agree whether it is the best option for the person.<\/p>\n\n\n\n

The purpose of the meeting is not simply to approve hiding medicines. It is to examine alternatives for each medicine and decide whether covert administration is genuinely necessary.<\/p>\n\n\n\n

That medicine-by-medicine approach matters. A resident may need covert administration for one essential tablet but not for every item on their MAR. One medicine may be stopped. Another may be changed to a liquid. Another may be given openly later in the day. Treating covert administration as a blanket status across the whole medicines profile is poor practice.<\/p>\n\n\n\n

The person\u2019s own wishes still matter<\/h2>\n\n\n\n

Even where a person lacks capacity, their wishes, values, beliefs and previous views still matter. Practitioners should take all reasonable steps to help the person provide their own views on the decision and should work with family, friends, advocates, attorneys and deputies to understand the person\u2019s wishes, values and decision-making history.<\/p>\n\n\n\n

That means care homes should not treat covert administration as purely clinical. It is also personal. Has the resident previously made clear views about medicines? Is there an advance decision? Are there cultural or communication factors affecting apparent refusal?<\/p>\n\n\n\n

Pharmacy advice is not optional<\/h2>\n\n\n\n

Once covert administration is being considered, the pharmaceutical issues become just as important as the legal ones. Crushing tablets, opening capsules or mixing medicines with food or drink may alter how the medicine works. Covert administration may involve altering medicines and is usually an unlicensed or off-label activity, so it requires prescriber authorisation, preferably in writing.<\/p>\n\n\n\n

This is a major safeguard. Not every medicine can be crushed. Not every medicine can be mixed with food. Some interact with milk. Some become unstable. Some must not be modified at all.<\/p>\n\n\n\n

For care homes, that means the best-interests decision is only half the job. The other half is making sure each medicine can actually be given in the agreed way without creating a new safety problem.<\/p>\n\n\n\n

The management plan must be specific<\/h2>\n\n\n\n

After the best-interests meeting, there should be a clear management plan. This would usually include a medication review by the GP, a pharmacist\u2019s review of how the medicine can be given covertly, clear documentation of the best-interests decision and a plan for regular review of whether covert administration should continue.<\/p>\n\n\n\n

A good care-home plan therefore needs more than \u201cgive covertly in yoghurt\u201d. It should state exactly which medicines are covered, how each one is prepared, what food or drink is suitable, who is authorised to give it, what staff should do if the resident refuses the food or drink, where the instructions are stored, and when the arrangement must be reviewed.<\/p>\n\n\n\n

General wording invites inconsistency across shifts. Specific wording supports safer practice.<\/p>\n\n\n\n

Urgent situations still need structure<\/h2>\n\n\n\n

Sometimes a medicine decision cannot wait for a fully convened formal meeting. In urgent cases a decision can be made through a discussion between care staff, the prescriber and the family member or advocate, as long as a formal best-interests meeting is arranged as soon as possible afterwards and the interim decision is recorded.<\/p>\n\n\n\n

That emergency flexibility is useful, but it is not a loophole. It does not remove the need for capacity assessment, best-interests reasoning or documentation. It simply allows the process to start in a less formal way where delay would create a greater risk.<\/p>\n\n\n\n

Review is not optional<\/h2>\n\n\n\n

Covert administration should never become permanent by inertia. The plan should be reviewed regularly to check whether it should continue.<\/p>\n\n\n\n

This is especially important in care homes because the reasons for refusal may change. A short course of antibiotics may finish. Pain may settle. Delirium may resolve. A new formulation may become available. A resident may regain enough understanding to make their own decision again. If the home does not actively review covert arrangements, what began as a justified short-term measure can become an unexamined routine.<\/p>\n\n\n\n

DoLS and wider restrictive practice issues<\/h2>\n\n\n\n

Covertly giving a medicine that affects behaviour or mental health may amount to continuous supervision and control and so create a Deprivation of Liberty Safeguards issue. That does not mean every covert medicine automatically triggers DoLS, but it does mean homes should be alert to the wider restrictive-practice picture when medicines are being used in this way.<\/p>\n\n\n\n

In practical terms, if covert medicines are part of a broader pattern of restraint, supervision or behavioural control, managers should not view them in isolation. The legal and safeguarding context may be wider than the medicine itself.<\/p>\n\n\n\n

Common mistakes care homes should avoid<\/h2>\n\n\n\n

Most covert medicines errors come from process failures, not from one dramatic incident. Common problems include:<\/p>\n\n\n\n